Tobias L. Freitag

Company: University of Helsinki

Job title: University Researcher, Group Leader

Seminars:

Biomarkers of Efficacy & Durability of Therapeutic Immunomodulation in Autoimmune Diseases: From Preclinical Models to the Clinic 4:45 pm

Use of mouse models of celiac disease and narcolepsy type I for testing efficacy of immunomodulatory compounds Biomarkers of immunomodulation in preclinical models of autoimmune diseases, and their development as exploratory endpoints for clinical trials Assessing durability in preclinical models, to explore persistence or repetitive loss of immune tolerance (once re-established by treatment)Read more

day: Conference Day One